Results 251 to 260 of about 167,693 (338)

Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Seery N   +36 more
europepmc   +1 more source

Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review

open access: yesPediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT TAFRO (thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly) syndrome is a rare, life‐threatening inflammatory condition linked to infections, neoplasms, and idiopathic multicentric Castleman disease. Interleukin (IL)‐6 inhibitors are the primary treatment, but refractory cases require alternatives. This
Serena Palmeri   +10 more
wiley   +1 more source

Males and females respond differently to treatment during isolated kidney perfusion: combined effects of glucocorticoid and estradiol. [PDF]

open access: yesFront Transplant
Vidal-Dos-Santos M   +9 more
europepmc   +1 more source

DONOR PRETREATMENT WITH CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE

open access: bronze, 1983
Henri L.F. Brom   +1 more
openalex   +1 more source

Corticosteroid‐responsive narcolepsy type II after COVID‐19: A relevant differential diagnosis of post‐COVID syndrome (a case report)

open access: yesJournal of Sleep Research, Volume 34, Issue 4, August 2025.
Summary Excessive daytime sleepiness is a possible symptom of post‐COVID syndrome and is also the cardinal symptom of narcolepsy, a rare life‐long sleep disorder with a possible autoimmune background. Recent reports indicate that COVID‐19 infection may trigger narcolepsy. However, it remains unclear how best to identify and treat such cases.
Erika C. S. Künstler   +4 more
wiley   +1 more source

Systemic lupus erythematosus associated with leukocytoclastic vasculitis: Report of a case treated by methylprednisolone pulse therapy

open access: bronze, 1986
Takamichi Yuhara   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy